Select NTD publications involving NTD-SC staff or funding are included below.

Finding hotspots: development of an adaptive spatial sampling approach

Scientific Reports, 2020; 10: 10939

Ricardo Andrade-Pacheco, Francois Rerolle, Jean Lemoine, Leda Hernandez, Aboulaye Meïté, Lazarus Juziwelo, Aurélien F. Bibaut, Mark J. van der Laan, Benjamin F. Arnold & Hugh J. W. Sturrock

Modelling | Lymphatic Filariasis and Schistosomiasis

In Silico Design and Validation of OvMANE1, a Chimeric Antigen for Human Onchocerciasis Diagnosis

Pathogens, 2020; 9: (6): 495

Cabirou Mounchili Shintouo, Robert Adamu Shey, Derrick Neba Nebangwa, Kevin K Esoh, Nkemngo Francis Nongley, Joel Ebai Nguve, Philippe Giron, Léon Mutesa, Luc Vanhamme, Jacob Souopgui, Stephen Mbigha Ghogomu, Rose Njemini

Diagnostics | Onchocerciasis

Review of MDA registers for Lymphatic Filariasis: Findings, and potential uses in addressing the endgame elimination challenges

PLOS Neglected Tropical Diseases, 2020; 14: (5): e0008306

Souza DK, Gass K, Otchere J, Htet YM, Asiedu O, et al.

Elimination | Lymphatic filariasis

The design and development of a multicentric protocol to investigate the impact of adjunctive doxycycline on the management of peripheral lymphoedema caused by lymphatic filariasis and podoconiosis

Parasites & Vectors, 2020; 13: 155

John Horton, Ute Klarmann-Schulz, Mariana Stephens, Philip J. Budge, Yaya Coulibaly, Alex Debrah, Linda Batsa Debrah, Suma Krishnasastry, Upendo Mwingira, Abdallah Ngenya, Samuel Wanji, Mirani Weerasooriya, Channa Yahathugoda, Inge Kroidl, Drew Deathe, Andrew Majewski, Sarah Sullivan, Charles Mackenzie, Thomas B. Nutman, Joseph P. Shott, Gary Weil, Eric Ottesen & Achim Hoerauf

Clinical Trials | Lymphatic filariasis

Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d'Ivoire based on Kato-Katz and POC-CCA: An open-label, randomised controlled trial (RePST)

PLOS Neglected Tropical Diseases, 2020; 14: (3): e0008189

Hoekstra PT, Casacuberta-Partal M, van Lieshout L, Corstjens PLAM, Tsonaka R, et al.

Clinical Trials | Schistosomiasis

The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial

PLOS Neglected Tropical Diseases, 2020; 14: (3): e0008106.

Hardy M, Samuela J, Kama M, Tuicakau M, Romani L, et al.

Clinical Trials | Lymphatic filariasis

A Tale of Two Parasites: Statistical Modelling to Support Disease Control Programmes in Africa

Statistical Science, 2020; 35: (1):42-50

Peter J. Diggle, Emanuele Giorgi, Julienne Atsame, Sylvie Ntsame Ella, Kisito Ogoussan, and Katherine Gass

Modeling | Onchocerciasis

Assessing the impact of aggregating disease stage data in model predictions of human African trypanosomiasis transmission and control activities in Bandundu province (DRC)

PLOS Neglected Tropical Diseases, 2020; 14: (1): e0007976

Castaño MS, Ndeffo-Mbah ML, Rock KS, Palmer C, Knock E, et al.

Modelling | Human African Trypanosomiasis

The Galabat-Metema cross-border onchocerciasis focus: The first coordinated interruption of onchocerciasis transmission in Africa

PLOS Neglected Tropical Diseases, 2020; 14: (2): e0007830

Katabarwa MN, Zarroug IMA, Negussu N, Aziz NM, Tadesse Z, et al.

Elimination | Onchocerciasis

Integrated Cross-Sectional Multiplex Serosurveillance of IgG Antibody Responses to Parasitic Diseases and Vaccines in Coastal Kenya

The American Journal of Tropical Medicine and Hygiene, 2020; 1: 164-176

Sammy M. Njenga, Henry M. Kanyi, Benjamin F. Arnold, Sultani H. Matendechero, Joyce K. Onsongo, Kimberly Y. Won, and Jeffrey W. Priest

Surveillance | Lymphatic filariasis